Results 181 to 190 of about 448,559 (305)

Lie Groups of Partial Differential Equations and Their Application to the Multidimensional Screening Problems [PDF]

open access: yes
In this paper I describe group theoretic methods that can be used for analyzing the boundary problems, which arise when the Hamiltonian method is applied to solve the relaxed problem for the multidimensional screening problem.
Suren Basov
core   +2 more sources

Belief change in branching time: AGM-consistency and iterated revision [PDF]

open access: yes
We study belief change branching-time structures. First, we identify a property of branching-time frames that is equivalent to AGM-consistency, which is defined as follows. A frame is AGM-consistent if the partial belief revision function associated with
Giacomo Bonanno
core  

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Isolation and partial characterization of antimicrobial peptide-enriched fractions from Parabacteroides distasonis. [PDF]

open access: yesSci Rep
Oliveira AGG   +6 more
europepmc   +1 more source

Growth inhibition of pathogenic microorganisms by Pseudomonas protegens EMM-1 and partial characterization of inhibitory substances. [PDF]

open access: yesPLoS One, 2020
Cesa-Luna C   +9 more
europepmc   +1 more source

Utilization ofp-aminobenzoyl glutamic acid in Escherichia coli: Partial characterization of a new gene cluster.

open access: yes, 1996
Utilization ofp-aminobenzoyl glutamic acid in Escherichia coli: Partial characterization of a new gene ...
Mouyassar Jawhar. Hussein (7989914)
core  

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Establishment and Partial Characterization of Canine Mammary Tumor Cell Lines. [PDF]

open access: yesAnimals (Basel)
Vazquez E   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy